CIBC analyst Kevin Chiang downgrades Canadian National Railway (TSX:CNR) from Outperformer to Neutral and announces C$182 price target.
BTIG Maintains Buy on Inari Medical, Lowers Price Target to $97
BTIG analyst Marie Thibault maintains Inari Medical (NASDAQ:NARI) with a Buy and lowers the price target from $100 to $97.